SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020
View ORCID ProfileAlyson Craigie, Reuben McGregor, Alana Whitcombe, Lauren Carlton, David Harte, Michelle Sutherland, Matthew Parry, Erasmus Smit, Gary McAuliffe, James Ussher, Nicole Moreland, Susan Jack, Arlo Upton
doi: https://doi.org/10.1101/2020.10.20.20215616
Alyson Craigie
aSouthern Community Laboratories, Dunedin, New Zealand
bDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
Reuben McGregor
cFaculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
dMaurice Wilkins Centre, University of Auckland, Auckland, New Zealand
Alana Whitcombe
cFaculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
dMaurice Wilkins Centre, University of Auckland, Auckland, New Zealand
Lauren Carlton
cFaculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
dMaurice Wilkins Centre, University of Auckland, Auckland, New Zealand
David Harte
eInstitute of Environmental Science and Research, Wellington, New Zealand
Michelle Sutherland
eInstitute of Environmental Science and Research, Wellington, New Zealand
Matthew Parry
fDepartment of Mathematics and Statistics, University of Otago, Dunedin, New Zealand
Erasmus Smit
eInstitute of Environmental Science and Research, Wellington, New Zealand
Gary McAuliffe
gLabtests, Auckland, New Zealand
hLabPlus, Auckland Hospital, Auckland, New Zealand
James Ussher
aSouthern Community Laboratories, Dunedin, New Zealand
bDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
Nicole Moreland
cFaculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
dMaurice Wilkins Centre, University of Auckland, Auckland, New Zealand
Susan Jack
iPublic Health South, Southern District Health Board, Dunedin, New Zealand
Arlo Upton
aSouthern Community Laboratories, Dunedin, New Zealand
Data Availability
The data that support the findings of this study are available from the corresponding author, AU, upon reasonable request.
Posted October 23, 2020.
SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020
Alyson Craigie, Reuben McGregor, Alana Whitcombe, Lauren Carlton, David Harte, Michelle Sutherland, Matthew Parry, Erasmus Smit, Gary McAuliffe, James Ussher, Nicole Moreland, Susan Jack, Arlo Upton
medRxiv 2020.10.20.20215616; doi: https://doi.org/10.1101/2020.10.20.20215616
SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020
Alyson Craigie, Reuben McGregor, Alana Whitcombe, Lauren Carlton, David Harte, Michelle Sutherland, Matthew Parry, Erasmus Smit, Gary McAuliffe, James Ussher, Nicole Moreland, Susan Jack, Arlo Upton
medRxiv 2020.10.20.20215616; doi: https://doi.org/10.1101/2020.10.20.20215616
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2936)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12740)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4579)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4346)
- Nursing (236)
- Nutrition (638)
- Oncology (2268)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)